NUEVOLUTION A/S: Financial statements 2018
CVR: 26029708
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
NUEVOLUTION A/S (CVR 26029708) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 8,125,000 and a net result of DKK -64,310,000 compared with DKK -16,535,000 the year before. That is a decrease of 91.2% compared with the year before. The profit margin was -791.5%. Equity in the 2018 report amounted to DKK 64,890,000. The solvency ratio was 83.5%.
- Revenue
- DKK 8,125,000
- Profit/Loss
- DKK -64,310,000
- Equity
- DKK 64,890,000
- Total Assets
- DKK 77,708,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 8.1 mio. | - | -64.3 mio. | 64.9 mio. | - |
| 2017 | 91.9 mio. | - | -16.5 mio. | 61.4 mio. | - |
| 2016 | 17 mio. | -37.4 mio. | -104.9 mio. | 15.6 mio. | - |
| 2015 | 23.9 mio. | -22.5 mio. | -43.9 mio. | 41.7 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of August 31, 2018, Henrik Damkjær Simonsen has stepped down as director of NUEVOLUTION A/S.
NUEVOLUTION A/S has published its interim report for the period July 1, 2017 – December 31, 2017.
As of May 8, 2018, Johnny Stilou is registered as director of NUEVOLUTION A/S.
About NUEVOLUTION A/S
NUEVOLUTION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CHEMGENE ApS. The management consists of Thomas Franch. The company is owned by Amgen, Inc.. The company has 59 employees (2018). In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. Equity in the 2025 report amounted to DKK 89,493,000.